Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.

Tarantino P, Lee D, Foldi J, Soulos PR, Gross CP, O'Meara T, Grinda T, Morganti S, Waks AG, Winer EP, Lin NU, Krop IE, Tolaney SM, Sammons S, Lustberg M

Open source

DOI: 10.1093/jnci/djaf220
Published: 2025 Nov 1
Container: Journal of the National Cancer Institute
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djaf220,
  title = {Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.},
  author = {Tarantino P and Lee D and Foldi J and Soulos PR and Gross CP and O'Meara T and Grinda T and Morganti S and Waks AG and Winer EP and Lin NU and Krop IE and Tolaney SM and Sammons S and Lustberg M},
  year = {2025},
  journal = {Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djaf220},
  url = {https://doi.org/10.1093/jnci/djaf220}
}

RIS

TY  - JOUR
TI  - Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.
AU  - Tarantino P
AU  - Lee D
AU  - Foldi J
AU  - Soulos PR
AU  - Gross CP
AU  - O'Meara T
AU  - Grinda T
AU  - Morganti S
AU  - Waks AG
AU  - Winer EP
AU  - Lin NU
AU  - Krop IE
AU  - Tolaney SM
AU  - Sammons S
AU  - Lustberg M
PY  - 2025
JO  - Journal of the National Cancer Institute
DO  - 10.1093/jnci/djaf220
UR  - https://doi.org/10.1093/jnci/djaf220
ER  -

APA

P, T., D, L., J, F., PR, S., CP, G., T, O., T, G., S, M., AG, W., EP, W., NU, L., IE, K., SM, T., S, S., & M, L. (2025). Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf220

Source records

pubmed · retrieved 2026-09-26T22:38:27.376Z